Merck & Co. Inc. (MRK) EVP, Chief HR Officer Owns Stock Worth $15000.0

Business man trader investor analyst using mobile phone app analytics for cryptocurrency financial stock market analysis analyze graph trading data index investment growth chart on smartphone screen.

Merck & Co. Inc. (NYSE:MRK) finished Thursday with a subtraction of -$0.26 to close at $110.82, a downside of -0.23 percent. An average of 5,524,500 shares of common stock have been traded in the last five days. There was a fall of -$0.29 in the past week, and it reached a new high 42 times over the past 12 months. The last 20 days have seen an average of 9,146,085 shares traded, while the 50-day average volume stands at 9,510,958.

MRK stock has increased by 1.82% in the last month. The company shares reached their 1-month lowest point of $107.32 on 12/12/22. With the stock rallying to its 52-week high on 12/28/22, shares of the company touched a low of $72.88 and a high of $112.89 in 52 weeks. It has reached a new high 43 times so far this year and achieved 44.60% or $34.18 in price. In spite of this, the price is down -1.83% from the 52-week high.

Will You Miss Out On This Growth Stock Boom?

A new megatrend in the fintech market is well underway. Mobile payments are projected to boom into a massive $12 trillion market by 2028. According to Motley Fool this growth stock could "deliver huge returns." Not only in the immediate future but also over the next decade. Especially since the man behind this company is a serial entrepreneur who has been wildly successful over the years.

And this is just one of our 5 Best Growth Stocks To Own For 2023.


Insider Transactions

MRK stock investors should be aware that Merck & Co. Inc. (MRK) stock had its last reported insider trading activity 50 days ago on Nov 10. In this transaction, the insider spent $1,521,278. President, U.S. Market, Oosthuizen Johannes Jacobus, disposed of 1,795 shares at a price of $103.21 on Nov 09. The insider now owns more than $185,262 worth of shares. Prior to that, CEO & President Davis Robert M went on to Sale 167,613 shares at $102.44 each on Nov 09. An amount of $17,169,840 was transacted.

Valuation Metrics

Merck & Co. Inc. (MRK) has a trailing price-to-earnings (P/E) ratio of 18.36. The stock’s beta is 0.40. Other valuation ratios to consider include the trailing price-to-sales (P/S) ratio at 4.74, the price-to-book (PB) ratio at 6.31, and the price-to-cash flow ratio at 33.49.

The company has a payout ratio of 45.80%. The company’s most recent quarterly dividend payment was $0.73 a share, representing a up of 5.8% from $0.69 last year. Its latest increase dividend $0.04 reported on Tuesday November 29 2022.

Financial Health

The quick ratio of Merck & Co. Inc. for the three months ended September 29 was 1.20, and the current ratio was 1.50, indicating that the company is able to meet its debt obligations. Further, the company has a long term debt to equity ratio of 0.64 and a total debt to equity ratio of 0.68 for the quarter ending September 29. Its gross profit as reported stood at $35.08 billion compared to revenue of $48.7 billion.

For investors, determining the potential profitability of the investment also depends on the performance of the company’s management. In the past 12 months, Merck & Co. Inc.’s return on assets was 14.30%.

Earnings Surprise

For the three-month period that ended September 29, Merck & Co. Inc. had $103.0 million in cash and short-term investments compared to $28.48 billion in total debt. In the quarter under review, the net income was up than the previous quarter. The company posted a net income of $3.25 billion in the quarter, while revenues of $3.94 billion were shrunk -40.61%. The analyst consensus anticipated Merck & Co. Inc.’s latest quarter earnings to come in at $1.71 per share, but it turned out to be $1.85, a 8.20% surprise. For the quarter, EBITDA amounted to $5.07 billion. Shareholders own equity worth $2.54 billion.

Technical Picture

From a technical analysis perspective, let’s take a brief look at Merck & Co. Inc. (MRK) price momentum. RSI 9-day as of the close on 29 December was 56.35%, suggesting the stock is Neutral, with historical volatility in this time frame at 9.18%.

As of today, MRK’s price is $111.42 -0.26% or -$0.29 from its 5-day moving average. MRK is currently trading +0.64% higher than its 20-day SMA and +25.23% higher than its 100-day SMA. However, the stock’s current price level is +17.13% above the SMA50 and +40.92% above the SMA200.

The stochastic %K and %D were 73.81% and 83.55%, respectively, and the average true range (ATR) was 1.57. With the 14-day stochastic at 62.84% and the average true range at 1.68, the RSI (14) stands at 60.56%. The stock has reached 0.61 on the 9-day MACD Oscillator while the 14-day reading was at 0.88.

Analyst Ratings

Credit Suisse launched coverage on Merck & Co. Inc. (NYSE: MRK) in its analyst report released on November 18, 2022. The firm assigned the stock an Outperform rating.


Please enter your comment!
Please enter your name here